01/16/2020 /
Recent epilepsy research news includes findings about “silencing” neurons to gain seizures control, enhanced understanding of how epilepsy affects memory, and more.
01/15/2020 /
Researchers have shown therapeutic efficacy of a new experimental drug in mouse models of Alzheimer’s disease and a rare genetic form of epilepsy known as Dravet syndrome.
01/15/2020 /
A clinical trial is evaluating the safety and tolerability of a nutritional formulation containing the ketone beta-hydroxybutyrate (BHB) as a treatment to help control seizures in children with Angelman syndrome.
01/14/2020 /
Researchers at Lund University in Sweden have used a neuropeptide to successfully reduce seizure-like activity in tissue from patients with drug-resistant epilepsy.
01/13/2020 /
Changes in norclobazam and clobazam levels do not have a clinically significant correlation with changes in weekly seizure frequency for those taking cannabidiol with clobazam.
01/13/2020 /
Researchers state that their robotic paradigm can detect impairments in various sensorimotor and cognitive functions across the population with epilepsy.
01/13/2020 /
VALTOCO is the first nasal spray approved by the FDA as a rescue treatment for people with epilepsy aged 6 and older
01/09/2020 /
The program will be expanded to make no-charge testing available for healthcare providers to order for any child under the age of eight who has an unprovoked seizure.
